TCTR20220318004
Enrolling By Invitation
Phase 2
Efficacy of triamcinolone acetonide dissolving microneedle patch for the treatment of hypertrophic scar and keloid: A randomized, double-blinded, placebo-controlled split-scar study
Division of Dermatology, Department of internal medicine, Faculty of medicine, Thammasat University0 sites10 target enrollmentMarch 18, 2022
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Triamcinolone acetonide dissolving microneedle patch for hypertrophic scar or keloid
- Sponsor
- Division of Dermatology, Department of internal medicine, Faculty of medicine, Thammasat University
- Enrollment
- 10
- Status
- Enrolling By Invitation
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Healthy male or female participants, aged 18\-60\.
- •2\. Participants had hypertrophic scar or keloid more than 2 cm without any previous treatments, more than 6 months of intralesional steroids, or more than 3 months of light \& laser treament.
- •3\. Participants who are willing to join the project after receiving a detailed description of the project and signing a consent form for the study.
- •4\. Participants can follow the testing method to follow up on treatment results throughout the study period and can report side effects that arise from the study immediately
Exclusion Criteria
- •1\. Participants who had history of treatment with intralesional steroids less than 6 months or light \& laser treatment less than 3 months.
- •2\. Participants who had a history of using systemic corticosteroids (oral, intramuscular, intravenous), chemotherapy, warfarin, heparin, or systemic retinoids
- •3\. Participants who had active dermatitis or skin infection at the study site
- •4\. Participants who are pregnant, breastfeeding or planning to become pregnant.
- •5\. Participants who had a history of liver diseases, renal diseases.
- •6\. Participants with any type of diabetes mellitus.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effectiveness of Triamcinolone Acetonide to surppress inflammation after eyelid surgeryJPRN-UMIN000032760Osaka Medical College50
Active, not recruiting
Not Applicable
se of auxiliary Triamcinolone acetonide in glaucoma surgery: a clinical trialGlaucomaC11.525.381RBR-53f8nhniversidade Federal de São Paulo
Not yet recruiting
Phase 2
Is triamcinolone acetonide useful and safe in meralgia paresthetica? Randomized control trialHealth Condition 1: null- Meralgia ParestheticaHealth Condition 2: G571- Meralgia parestheticaCTRI/2017/10/010000Delhi Neurological Association
Recruiting
Phase 2
Investigating the effect of triamcinolone acetate injection in the lower branches of the nose in improving the symptoms and quality of life of patients with allergic rhinitis undergoing rhinoplastyallergic rhinitis.Other allergic rhinitisIRCT20171008036655N2Zahedan University of Medical Sciences100
Recruiting
Phase 4
Comparative outcome of triamcinolone acetonide injection between 10 mg and 20 mg in de Quervain Tenosynovitis : A randomized controlled trialTriamcinolone acetonide injection in de Quervain Tenosynovitisde Quervain Tenosynovitis, Triamcinolone acetonide injection, TA injectionTCTR20240429004Mahavajiralongkorn Phramongkutklao Hospital Foundation122